TRANSITIONAL CELL CARCINOMA
Clinical trials for TRANSITIONAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSITIONAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bladder cancer trial combines targeted drug with chemo
Disease control OngoingThis study tests a new three-drug combination for people with advanced bladder cancer that has spread or cannot be removed by surgery. The goal is to find the safest dose and see if the combination shrinks tumors. About 57 participants will receive the targeted drug ixazomib plus…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC